Sponsor or institution
Clinical trials and research at Shanghai EpimAb Biotherapeutics Co., Ltd.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Shanghai EpimAb Biotherapeutics Co., Ltd. that are recruiting, in China. By phase: Phase 1 (2), Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| EMB-01 plus chemotherapy for unresectable or metastatic colorectal cancer | Phase 1 | Beijing, Beijing Municipality and 1 other locations | Recruiting | Jun 16, 2026 |
| First-in-human test of EMB-15 in adults with advanced or metastatic solid tumors | Phase 1 | Guangzhou, Guangdong | Recruiting | May 26, 2026 |
| EMB-07 combination therapy in aggressive B-cell non-Hodgkin lymphoma | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Feb 25, 2026 |
| EMB-01 dosing for recurrent or metastatic left-sided colorectal cancer | Phase 2 | Beijing and 1 other locations | Recruiting | Jan 2, 2026 |
All recruiting trials (4)
-
EMB-01 plus chemotherapy for unresectable or metastatic colorectal cancer
This early-phase trial tests EMB-01 in combination with chemotherapy to see if it is safe and helps treat people with unresectable or metastatic colorectal cancer.
-
First-in-human test of EMB-15 in adults with advanced or metastatic solid tumors
This early phase trial tests EMB-15 to see if it is safe and tolerable in adults whose solid tumors have progressed after standard care or have no standard therapy.
-
EMB-07 combination therapy in aggressive B-cell non-Hodgkin lymphoma
This trial tests EMB-07 with rituximab, gemcitabine, and oxaliplatin to see if it is safe and tolerable and to get a hint of benefit in adults with aggressive B-cell non-Hodgkin lymphoma.
-
EMB-01 dosing for recurrent or metastatic left-sided colorectal cancer
This trial tests two dosing schedules of EMB-01 in adults with recurrent or metastatic KRAS/BRAF wild-type left-sided colorectal cancer after first- or second-line treatment.
Quick answers
How many clinical trials run by Shanghai EpimAb Biotherapeutics Co., Ltd. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.